RIKEN Immune Regenerative Medicine Inc. is a venture company spun off from RIKEN, the Japan's largest comprehensive Science Research Institute.

ABOUTAbout us

We will promote further
research and development.

弊社の業務提携に関する方針について | イメージ画像

We develop highly safe drugs and culture methods that are essential for NKT cell-targeted therapy, perform cell cultures under the guidance of affiliated medical institutions, and provide medical treatments that are not covered by insurance to patients.We will continue to expand our network of affiliated medical institutions and further research and development with an emphasis on evidence.